ALL WOMEN SHOULD RECEIVE CONTINUOUS MONITORING OF FETAL HEART RATE AND UTERINE ACTIVITY WITH SPECIAL ATTENTION TO HYPERSTIMULATION, PRESENCE OF NON REASSURING TRACING ABSENT VARIABILITY, REPETITIVE VARIABLE OR LATE DECELERATION, OR BRADYCARDIA, AND D ALL WOMEN SHOULD RECEIVE CONTINUOUS MONITORING OF FETAL HEART RATE AND UTERINE ACTIVITY WITH SPECIAL ATTENTION TO HYPERSTIMULATION, PRESENCE OF NON REASSURING TRACING ABSENT VARIABILITY, REPETITIVE VARIABLE OR LATE DECELERATION, OR BRADYCARDIA, AND D
121 veces visto
Ayúdanos a mantener la plataforma en funcionamiento y eliminar todos estos banners. 🥺
